Dr. Ryan Zarychanski, University of Manitoba, Winnipeg, MB

This session will provide an overview of COVID-19 therapeutic strategies including anti-virals, immunomodulation, and anti-inflammatory drugs. Given emerging data, the presentation of data will focus on anti-coagulant and anti-platelet therapies both on the ward and in the ICU.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Discuss current evidence-informed strategies to treat COVID-19
  • Select patients who are likely to benefit from empiric therapeutic anticoagulation

CanMEDs Competencies Addressed:
Medical Expert